Share story
Security AI

Benchling deploys isolated AI code execution across 250 life-sciences tenants

Benchling deploys isolated AI code execution across 250 life-sciences tenants Image: Primary
Benchling says its security architecture now processes more than 600 AI-generated code-execution sessions daily across more than 250 life-sciences tenants each week, with no security incidents reported. The deployment runs Amazon Bedrock AgentCore Code Interpreter in a separate AWS account with no internet or NAT gateway. Route 53 DNS Firewall blocks unapproved domain resolution, VPC endpoint policies limit reachable storage buckets, and temporary credentials restrict each job to one tenant's data. Benchling continuously tests attempted DNS tunneling, unauthorized connections and access to unapproved buckets, but the performance and incident figures come from the companies' account.
Sources
Artificial Intelligence
In this story
Amazon
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Artificial Intelligence and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Onlinekhabar English
Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

Infosecurity Magazine
AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Techmeme
Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...

EU-Startups